(Q40406446)

20 September 2017

1 reference

title

The urokinase/urokinase-receptor system and cancer invasion (English)

1 reference

20 September 2017

1 reference

1

1 reference

20 September 2017

Blasi F

2

1 reference

PubMed ID

7549068

20 September 2017

language of work or name

1 reference

1 June 1995

1 reference

Best Practice and Research: Clinical Haematology

20 September 2017

1 reference

20 September 2017

8

1 reference

20 September 2017

365-389

1 reference

20 September 2017

2

1 reference

Plasminogen activator inhibitors: hormonally regulated serpins

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Cryptic urokinase binding sites on human foreskin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Protease-nexin: A cellular component that links thrombin and plasminogen activator and mediates their binding to cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Tyrosine phosphorylation of human urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The plasmin system in human colonic tumors: an immunofluorescence study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Physiological consequences of loss of plasminogen activator gene function in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

PMA-induced down-regulation of the receptor for alpha 2-macroglobulin in human U937 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Urokinase plasminogen activator and prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Glycosaminoglycans on fibroblasts accelerate thrombin inhibition by protease nexin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Human urokinase-type plasminogen activator stimulates chemotaxis of human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Structural relationship between human high and low molecular mass urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The urokinase receptor is required for human monocyte chemotaxis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Characterization of the receptor for protease nexin-I:protease complexes on human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Partial Purification and Properties of Urokinase Inhibitor from Human Placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The cellular target for the plasminogen activator, urokinase, in human fibroblasts - 66 000 dalton protein

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The release of heparin binding peptides from platelet thrombospondin by proteolytic action of thrombin, plasmin and trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of laminin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Characterization of the activation of pro-urokinase by thermolysin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Serine phosphorylation of biosynthetic pro-urokinase from human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Biology and biochemistry of proteinases in tumor invasion.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The alpha 2-macroglobulin receptor and epithelial glycoprotein-330: two giant receptors mediating endocytosis of multiple ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Immunocytochemical identification of the human alpha 2-macroglobulin receptor in monocytes and fibroblasts: monoclonal antibodies define the receptor as a monocyte differentiation antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Structural requirements for glycosyl-phosphatidylinositol-anchor attachment in the cellular receptor for urokinase plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Distribution and lateral mobility of the urokinase-receptor complex at the cell surface.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Urokinase receptors in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Identification and characterization of urokinase receptors in natural killer cells and T-cell-derived lymphokine activated killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Rat mammary carcinoma cells secrete active collagenase and activate latent enzyme in the stroma via plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Antibodies to plasminogen activator inhibit human tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Protease resistance and conformation of laminin.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Upregulation of urokinase receptor expression on migrating endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Structure-function relationships in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom alpha-neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The plasminogen-activation system in ovarian tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Modulation of activities and RNA level of the components of the plasminogen activation system during fusion of human myogenic satellite cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Plasminogen activators are involved in keratinocyte and fibroblast migration in wounded cultures in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The receptor for the plasminogen activator of urokinase type is up-regulated in transformed rat thyroid cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Processing of complex between urokinase and its type-2 inhibitor on the cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Identification of a protease inhibitor produced by astrocytes that is structurally and functionally homologous to human protease nexin-I.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Role of specific membrane receptors in urokinase-dependent migration of human keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Selective localization of receptors for urokinase amino-terminal fragment at substratum contact sites of an in vitro-established line of human epidermal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Differential protease expression by cutaneous squamous and basal cell carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Urokinase-type plasminogen activator in colorectal carcinomas and adenomatous polyps: quantitative expression of active and proenzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Autocrine saturation of pro-urokinase receptors on human A431 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and alpha 2-antiplasmin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicle.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

Breast cancer prognosis is poor when total plasminogen activator activity is low

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980273-2

7 January 2021

10.1016/S0950-3536(05)80273-2

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7549068